In a significant move that could revolutionize the medical device industry, Avinger Inc. has been granted a new U.S. patent. This cutting-edge patent, numbered #11903677, encompasses occlusion-crossing devices, imaging, and atherectomy devices. This development is not just important for Avinger and its stakeholders but also holds immense potential implications for patients and healthcare providers across the co...
steven smith38 : そこで28のシェアを試してみてください。我々は14の株式を保有しています。ありがとうございます。
Trytosaveabit スレ主 steven smith38 : GL